Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. AstraZeneca’s Imfinzi looks to maintenance setting in advanced NSCLC to reverse fortunes
  2. Why are over half of newly-approved cancer drugs failing to deliver?
  3. Anacetrapib failure marks the death of the CETP class of cholesterol-lowering therapies
  4. Huge drug development opportunities in global immuno-oncology area in Asia-Pacific
  5. Deals this week: GlycoMimetics, Erytech Pharma, ObsEva

Latest Content

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top